Stock Value: Comprehensive Guide for Investing in the Stock Market

The value of stocks is a central concept in market finance and investment. Understanding how to evaluate and choose stocks with high potential is essential for any investor looking to optimize their portfolio. This comprehensive guide aims to illuminate the fundamental principles of stock valuation, relying on the latest analytical methods, up-to-date market information, and concrete examples such as ValiRx plc, specializing in biotechnology.

Introduction to Stock Value

The value of a stock reflects the price at which a financial security is traded on a stock exchange. This price, constantly evolving, depends on multiple factors such as the financial health of the company, industry trends, the global economic context, supply and demand, as well as investor expectations. Mastering the mechanisms of stock valuation is crucial for anyone who wishes to invest intelligently and limit risks associated with market volatility.

What is a stock?

A stock represents a fraction of the share capital of a listed company. Holding one or more shares makes you a shareholder, involved proportionally in the results, losses, and potentially strategic decisions of the issuing entity. Being a shareholder entitles you to receive dividends (if the company distributes them), to participate in general meetings, and possibly to benefit from an increase in value upon resale of the securities. Stocks trade on various exchanges such as Euronext Paris, the London Stock Exchange, or NASDAQ.

Factors that influence the value of stocks

  • Company performance: Revenue, profitability, growth in earnings, or management of the balance sheet predominantly influence the price of a stock.
  • Economic conditions: Economic cycles, inflation, monetary policy decisions, and GDP growth condition investors' appetite for risk.
  • Industry situation: Specific trends within each sector (technology, biotechnology, finance, energy, etc.) induce different dynamics on the stock markets.
  • Market analysis and expectations: Expectations regarding future profits, innovation, or development prospects can change the price independently of past financial statements.
  • Shareholding structure and governance: A reputable management team, a stable or strategic shareholding base favors the stability of a value.

Analysis of Stock Value

Accurately evaluating the value of a stock involves a multidimensional analysis of both the company, its sector, and the general stock market context. Two main approaches stand out: fundamental analysis and technical analysis.

Fundamental Analysis

Fundamental analysis examines all available financial and economic data to estimate the "intrinsic value" of a security. The main criteria studied are:

  • The price-to-earnings ratio (P/E): This indicator relates the stock price to the earnings per share. If the earnings are negative, as is often the case for many innovative biotech companies, this ratio is not applicable ("N/A").
  • Earnings per share (EPS): It expresses the net earnings attributed to each outstanding share.
  • Profit margin: Indicates the proportion of profit generated after all expenses relative to revenue.
  • Level of indebtedness: High levels of debt can represent a financial risk, especially in times of rising interest rates.
  • Cash and cash flow: They inform on the company’s ability to self-finance and its resilience against market cycles.

It is essential to compare these ratios and aggregates both sectorally and historically to identify undervalued or overvalued companies. In particular, the analysis should be nuanced for high-growth or high-research and development (R&D) intensity companies.

Case Study: ValiRx plc (VAL.L)

For example, we analyze here the company ValiRx plc, operating in the life sciences and biotechnology sectors, listed on the London Stock Exchange.

  • ISIN Code: GB00BLH13C52
  • Stock Symbol: VAL.L
  • Market: London Stock Exchange (AIM)
  • Industry Sector: Healthcare
  • Industry Subsector: Biotechnology
  • Current Share Price: approximately 5.95 GBX (about 0.069 EUR) as of November 11, 2025
  • Market Capitalization: approximately 13.6 million British pounds (around 15.6 million euros)
  • Dividend: 0% (no dividends paid)
  • P/E Ratio: N/A (negative earnings)
  • Beta: Data not published or irrelevant for the period considered due to low liquidity
  • Total Number of Shares Outstanding: approximately 742,721,072
  • Average Daily Trading Volume: around 1 million shares based on recent sessions

ValiRx plc primarily operates in the development of innovative therapies for cancer and women's health. Its stock price reflects both its status as a research company (limited revenues, recurring operating losses) and the anticipation of potential successes in future clinical trials, typical factors for pre-commercial biotech companies. The volatility of such stocks is significant, as well as trading volumes during strategic announcements or fundraising events. Note that ValiRx does not distribute any dividends at present, with any potential gains resting on future valuation and innovation prospects.

Traditional financial ratios (especially the P/E ratio) are thus not relevant; evaluation mainly relies on the analysis of the research pipeline, the strength of cash reserves, partnerships, and the ability to raise funds without overly diluting existing shareholders.

Technical Analysis

Tech analysis focuses on studying price trends, traded volumes, and graphical patterns to try and predict future market movements. Its main tools are:

  • Japanese candlestick charts: They visualize price variations over different periods and help detect reversal or continuation signals.
  • Tech indicators: Moving averages, RSI (Relative Strength Index), MACD (Moving Average Convergence Divergence) to detect overbought or oversold cycles, as well as optimal entry or exit points.
  • Supports and resistances: These are psychological thresholds corresponding to price floors or ceilings reached multiple times and likely to cause rebounds or break trends.

Tech analysis is appreciated by active investors and short-term traders looking to benefit from market volatility. However, on micro-caps or illiquid companies, signals are less reliable and should be cross-referenced with fundamental analyses and current events.

Investment Strategies in Stocks

Investing in stocks requires selecting a strategy aligned with your investment horizon, risk profile, and financial goals. Here are the main methods adopted by professional and individual investors:

  • Value investing: This approach involves seeking undervalued companies by the market, presenting potential for turnaround or future growth. The goal is to acquire at a good price shares accompanied by solid fundamentals.
  • Growth strategy: It involves betting on businesses with revenue and earnings growth above average market levels, even at higher multiples. Technology and biotech companies often attract this type of investor.
  • Dividend: Selecting stocks that regularly pay a portion of their profits as dividends appeals to profiles seeking stable and recurring income. Note, ValiRx does not fit this profile as it does not pay dividends.
  • Momentum trading: Betting on the strength of trends, this method aims to capture rapid rises using technical indicators.
  • Passive investment: Long-term purchase of ETFs or index funds allows automatic diversification and limits individual risk.

No matter the chosen style, it is advisable to diversify positions and limit exposure to overly speculative or very low liquidity values.

How to Interpret Stock Market Figures

Knowing how to read and interpret stock market data is essential to evaluate the value and potential of a stock. Here are the main indicators and their meanings:

  • The stock price: This is the price at which the stock trades at a given moment. It is expressed in the local currency of the relevant market (e.g., GBX for many London Stock Exchange stocks).
  • The market capitalization: This refers to the total market value of all the shares of a company. To calculate it, multiply the number of outstanding shares by the latest known stock price.
  • The trading volume: This expresses the number of shares traded over a given period. A high volume generally indicates increased interest, whether buying or selling.
  • The beta: Measures the sensitivity of the stock relative to the overall market. However, this figure has little relevance for micro-cap or very illiquid stocks.
  • The P/E ratio (Price/Earnings Ratio): Indicates the level of earnings valuation, useful for profitable companies. For loss-making companies like ValiRx, it is marked "N/A" (not applicable).
  • The dividend yield: This is the portion of profits distributed to shareholders in the form of dividends, relative to the stock price. A yield of 0% means no dividend is paid.

The Key Steps in Stock Investment

  • Opening a brokerage account or PEA: A prerequisite for any purchase/sale of stocks through a broker or bank. The PEA (Plan d'Épargne en Actions) offers certain tax advantages for French residents.
  • Selecting stocks: This step relies on fundamental analysis, sector outlooks, and your personal criteria (profitability, dividends, growth, innovation, etc.).
  • Portfolio management: Regular monitoring of held values, arbitrations based on market events, and potential reinvestment of capital gains or dividends.
  • Risk management: Sectoral and geographic diversification, limiting exposure to speculative stocks, and setting loss thresholds ("stop loss").
  • Understanding taxation: Capital gains, dividends, and distributions are subject to local taxes (social security contributions, income tax, etc.). Anticipating the impact of taxation allows optimizing investment choices.

A Closer Look at the Valuation of a Biotech Startup: The Case of ValiRx plc

Biotechnology listed companies, such as ValiRx plc, differ significantly from traditional stocks in terms of stock valuation. In the absence of recurring profits and revenues, valuation primarily depends on:

  • The quality and advancement of the scientific pipeline: The further clinical trials advance towards late phases, the greater the potential value.
  • The size of the addressable market: An innovative treatment for a rare disease or a common cancer does not generate the same revenue expectations.
  • Strategic partnerships and funding: The entry of institutional investors, agreements with major laboratories, or success in fundraising rounds are all positive signals.
  • Financial strength: In the case of ValiRx, recent fundraisings ensure the continuation of research projects, but the lack of revenue requires close monitoring of available cash and management of dilution.

The savvy investor should therefore monitor both the company's ability to reach its clinical milestones and the dynamics of its financial communications and interactions with the markets. Key events to follow include the release of interim results, announcements of partnerships, and any information on the development pipeline.

Understanding the Risks of Investing in Stocks

  • Volatility: Stock prices can change rapidly, sometimes without an obvious fundamental reason, due to speculation, lack of liquidity, or the impact of news.
  • Sector and company risk: An innovative biotech company depends on the success of its research and clinical trials, which can lead to significant fluctuations in valuation.
  • Dilution risk: On companies that regularly raise funds like ValiRx, there is a risk of an increase in the number of shares in circulation and thus dilution of the value per share held.
  • Market risk: Economic, geopolitical crises, or a sector reversal test the resilience of stock portfolios.
  • Lack of dividends: Some companies, especially those in a developmental stage like ValiRx, do not pay dividends and any returns depend solely on the potential rise in stock price.

Frequently Asked Questions About the Value of Stocks

  • How to calculate the value of a stock? It is the product of the total number of shares in circulation by the price of the stock on a given date, which gives the market capitalization. For a detailed analysis, it is also necessary to evaluate the financial structure, growth potential, and sectoral context.
  • Where does the volatility of stocks come from? This volatility is due to the rapid spread of information, psychological reactions of investors, economic announcements, and low visibility on the long-term prospects of some companies.
  • What are the main stock ratios to know? PER (Price/Earnings), price/book value ratio, dividend yield, debt ratio... Their relevance varies according to the maturity of the company being studied.
  • Why do some stocks not show a PER ratio or dividends? Because they do not generate net profits or have chosen not to distribute dividends, a frequent situation in emerging or innovative sectors.
  • Is investing in micro-caps like ValiRx risky? Yes, micro-caps exhibit exaggerated volatility, sometimes low liquidity, and are generally more exposed to dilution and financing cycles.

Conclusion

Knowing how to appreciate the value of a stock is a fundamental skill for successfully investing in the stock market. The example of ValiRx plc perfectly illustrates the differences in approach between the analysis of mature companies and innovative companies, highlighting the need to use reliable, recent, and official platform data. Regularly comparing fundamental analysis, technical analysis, and sector news allows the investor to make rational decisions, while keeping in mind that risk is an integral part of the stock universe.

To go further, it is recommended to consult in-depth analyses, participate in specialized training, and diversify investments. Discipline, vigilance, and systematic verification of data are the keys to successful equity market investment.